Table 1. Probability of event and probability of success and complications for patients following second line intervention.
| Event | Probability intervention (%) | Study | Probability success (%) | Study |
|---|---|---|---|---|
| Second line PDE-5I | 77 | * | 60 | Kucuk, 2016 (8) |
| ICI (trimix or alprostadil) | 20 | * | 70 | Linet, 1996 (14); Rajpurkar, 2003 (15) |
| IPP | 2 | Lee, 2015 (9) | 85 | Rajpurkar, 2003 (15) |
| ICI trimix→priapism | 20 | Sung, 2014 (16); Eardley, 2010 (17) | ||
| ICI alprostadil→priapism | 5 | Linet, 1996 (14) | ||
| IPP→failure | 15 | Mirheydar, 2016 (18) |
*, no direct value available in literature/surrogate. PDE5-I, phosphodiesterase-5-inhibitors; ICI, intracorporal injection; IPP, inflatable penile prosthesis placement.